Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 5/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | ACHE | P22303 | 2/20 | 0.52 |
| ▸ | PRKDC | P78527 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.39 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.39 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.39 |
| ▸ | ABAT | P80404 | 1/20 | 0.39 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1225577 | 0.89 | ERN1 (0.52) | ERN1ALDH1A1SMN1; SMN2ACHEPRKDC | |
| SCHEMBL12581710 | 0.86 | PRKDC (0.53) | ERN1ALDH1A1SMN1; SMN2ACHEPRKDC | |
| SCHEMBL5358719 | 0.86 | ERN1 (0.68) | ERN1ALDH1A1SMN1; SMN2ACHEPRKDC | |
| SCHEMBL22090609 | 0.85 | ERN1 (0.45) | ERN1ALDH1A1SMN1; SMN2ACHEPRKDC | |
| SCHEMBL1225504 | 0.84 | ERN1 (0.47) | ERN1ALDH1A1SMN1; SMN2ACHEPRKDC | |
| SCHEMBL26353994 | 0.84 | ERN1 (0.47) | ERN1ALDH1A1SMN1; SMN2ACHEPRKDC | |
| SCHEMBL13362398 | 0.81 | ALDH1A1 (0.59) | ERN1ALDH1A1SMN1; SMN2PRKDCTDP1 | |
| 2,4,6-Trimethoxybenzaldehyde SCHEMBL34873 | 0.81 | ERN1 (0.74) | ERN1ALDH1A1PRKDCTDP1TSHR | |
| SCHEMBL439961 | 0.81 | ERN1 (0.52) | ERN1ALDH1A1SMN1; SMN2PRKDCTDP1 | |
| SCHEMBL18763593 | 0.79 | ERN1 (0.50) | ERN1ALDH1A1SMN1; SMN2PRKDCTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230148641-A1 | FLAVOR COMPOSITION | FIRMENICH SA (CH) | 2023-05-18 | — | — | US | claimed |
| EP-4125427-A1 | FLAVOR COMPOSITION | Firmenich SA (CH) | 2023-02-08 | — | — | EP | claimed |
| CN-115279206-A | Flavor composition | 弗门尼舍有限公司 | 2022-11-01 | — | — | CN | claimed |
| WO-2021198199-A1 | FLAVOR COMPOSITION | FIRMENICH SA (CH) | 2021-10-07 | — | — | WO | claimed |
| US-20260021061-A1 | ARIADNE AND ANALOGS FOR THE TREATMENT OF NEUROLOGICAL AND NEUROMUSCLAR DISORDERS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2026-01-22 | — | — | US | disclosed |
| EP-4680039-A1 | COMPOSITIONS FOR REDUCING OFF NOTES AND USES THEREOF | DSM-Firmenich AG (CH) | 2026-01-21 | — | — | EP | disclosed |
| US-20250289789-A1 | REVERSIBLE LYSINE COVALENT MODIFIERS OF CDK2 AND USES THEREOF | TERREMOTO BIOSCIENCES, INC. | 2025-09-18 | — | — | US | disclosed |
| WO-2025090658-A2 | REVERSIBLE LYSINE COVALENT MODIFIERS OF CDK2 AND USES THEREOF | TERREMOTO BIOSCIENCES, INC. (US) | 2025-05-01 | — | — | WO | disclosed |
| WO-2024251755-A1 | COMPOSITIONS FOR REDUCING OFF NOTES AND USES THEREOF | DSM-FIRMENICH AG (CH) | 2024-12-12 | — | — | WO | disclosed |
| WO-2024073601-A2 | ARIADNE AND ANALOGS FOR THE TREATMENT OF NEUROLOGICAL AND NEUROMUSCLAR DISORDERS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2024-04-04 | — | — | WO | disclosed |
| US-20240109836-A1 | NON-HALLUCINOGENIC ARIADNE ANALOGS FOR TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2024-04-04 | — | — | US | disclosed |
| US-11773085-B2 | Methods and compounds for treating disorders | FOGHORN THERAPEUTICS INC. (US) | 2023-10-03 | — | — | US | disclosed |
| US-20070082888-A1 | POLYARYLCARBOXAMIDES USEFUL AS LIPID LOWERING AGENTS | MEERPOEL LIEVEN | 2007-04-12 | — | — | US | disclosed |
| US-7169796-B2 | Polyarylcarboxamides useful as lipid lowering agents | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-01-30 | — | — | US | disclosed |
| WO-2003076401-A1 | SULFONYLAMINO-DERIVATIVES AS NOVEL INHIBITORS OF HISTONE DEACETYLASE | JANSSEN PHARMACEUTICA N.V. (BE) | 2003-09-18 | — | — | WO | disclosed |
| WO-2003076395-A1 | CARBONYLAMINO-DERIVATIVES AS NOVEL INHIBITORS OF HISTONE DEACETYLASE | JANSSEN PHARMACEUTICA N.V. (BE) | 2003-09-18 | — | — | WO | disclosed |
| US-4806141-A | 1-OXY-2-OXIMO-3-OXO-5-PHENYL CYCLOMEXENE | ICI AUSTRALIA LIMITED (AU) | 1989-02-21 | — | — | US | disclosed |
| EP-0085530-B1 | CYCLOHEXANE DIONE DERIVATIVES, THEIR USE AS HERBICIDES, HERBICIDAL COMPOSITIONS CONTAINING THEM, AND METHODS OF PREPARING THEM | ICI AUSTRALIA LIMITED (AU) | 1987-07-01 | — | — | EP | disclosed |
| EP-0085530-A2 | Cyclohexane dione derivatives, their use as herbicides, herbicidal compositions containing them, and methods of preparing them | ICI AUSTRALIA LIMITED (AU) | 1983-08-10 | — | — | EP | disclosed |
| US-4024274-A | Benzylamine derivatives and process for preparing them | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250289789-A1 | REVERSIBLE LYSINE COVALENT MODIFIERS OF CDK2 AND USES THEREOF | CDK2, CDK20, CDK1 | ERN1 1389/4885ALDH1A1 3042/4885SMN1; SMN2 2895/4885 |
| US-20240109836-A1 | NON-HALLUCINOGENIC ARIADNE ANALOGS FOR TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS | HTR2C, HTR3A, CNR2 | ERN1 4270/4885ALDH1A1 1723/4885SMN1; SMN2 1163/4885 |
| US-11773085-B2 | Methods and compounds for treating disorders | VHL, TFEB, BECN1 | ERN1 1427/4885ALDH1A1 2034/4885SMN1; SMN2 143/4885 |
| US-20260021061-A1 | ARIADNE AND ANALOGS FOR THE TREATMENT OF NEUROLOGICAL AND NEUROMUSCLAR DISORDERS | ATXN2, HCRTR2, CDR2 | ERN1 4251/4885ALDH1A1 402/4885SMN1; SMN2 4/4885 |
| US-20070082888-A1 | POLYARYLCARBOXAMIDES USEFUL AS LIPID LOWERING AGENTS | LIPC, PNLIP, APOB | ERN1 2488/4885ALDH1A1 1370/4885SMN1; SMN2 4407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.